64 related articles for article (PubMed ID: 3259486)
1. Use of the Haemophilus influenzae type b vaccine among preschool attendees.
Gilsdorf JR
Clin Pediatr (Phila); 1988 Jun; 27(6):285-8. PubMed ID: 3259486
[TBL] [Abstract][Full Text] [Related]
2. Immunization with oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine on a large health maintenance organization population: extended follow-up and impact on Haemophilus influenzae disease epidemiology. The Kaiser Permanente Pediatric Vaccine Study Group.
Black SB; Shinefield HR
Pediatr Infect Dis J; 1992 Aug; 11(8):610-3. PubMed ID: 1523069
[TBL] [Abstract][Full Text] [Related]
3. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era.
Adams WG; Deaver KA; Cochi SL; Plikaytis BD; Zell ER; Broome CV; Wenger JD
JAMA; 1993 Jan; 269(2):221-6. PubMed ID: 8417239
[TBL] [Abstract][Full Text] [Related]
4. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
[TBL] [Abstract][Full Text] [Related]
5. [Effectiveness of Haemophilus influenzae B-diphtheria conjugate vaccination in German children].
Zielen S; Scheurer J; Rhodius U; Schäfer V; Isenberg H; Bauscher P; Schröder S; Ahrens P; Hofmann D
Monatsschr Kinderheilkd; 1992 Dec; 140(12):852-6. PubMed ID: 1491705
[TBL] [Abstract][Full Text] [Related]
6. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
Cochi SL; Broome CV; Hightower AW
JAMA; 1985 Jan; 253(4):521-9. PubMed ID: 3918181
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
Walter EB; Moggio MV; Drucker RP; Wilfert CM
Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
[TBL] [Abstract][Full Text] [Related]
8. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.
Adderson EE; Chisholm N; Halperin SA
Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine.
Shapiro ED; Berg AT
Pediatrics; 1990 Apr; 85(4 Pt 2):643-7. PubMed ID: 2179854
[TBL] [Abstract][Full Text] [Related]
10. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae type B conjugate vaccines.
Force RW; Lugo RA; Nahata MC
Ann Pharmacother; 1992 Nov; 26(11):1429-40. PubMed ID: 1477450
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a fourth dose of Haemophilus influenzae type b (Hib) conjugate vaccine and antibody persistence in young children from the United Kingdom who were primed with acellular or whole-cell pertussis component-containing Hib combinations in infancy.
Southern J; McVernon J; Gelb D; Andrews N; Morris R; Crowley-Luke A; Goldblatt D; Miller E
Clin Vaccine Immunol; 2007 Oct; 14(10):1328-33. PubMed ID: 17699835
[TBL] [Abstract][Full Text] [Related]
13. The introduction of Haemophilus influenzae B (Hib) vaccine.
Murphy JF
Ir Med J; 1992 Dec; 85(4):123. PubMed ID: 1473940
[No Abstract] [Full Text] [Related]
14. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
[TBL] [Abstract][Full Text] [Related]
15. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.
Granoff DM; Weinberg GA; Shackelford PG
Pediatr Res; 1988 Aug; 24(2):180-5. PubMed ID: 3263612
[TBL] [Abstract][Full Text] [Related]
16. National Advisory Committee on Immunization (NACI). Statement on Haemophilus influenzae type B conjugate vaccines for use in infants and children.
Can Commun Dis Rep; 1992 Dec; 18(23):169-76. PubMed ID: 1291012
[TBL] [Abstract][Full Text] [Related]
17. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
Peltola H; Käyhty H; Sivonen A; Mäkelä H
Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348
[TBL] [Abstract][Full Text] [Related]
18. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
[TBL] [Abstract][Full Text] [Related]
19. [Tolerance and immunogenicity of the capsular polyoside vaccine against Haemophilus influenzae type b. A study of 325 children 15 to 71 months of age].
Reinert P; Postel-Vinay A; Bessa E; Hessel L; Schulz D; Cadoz M
Ann Pediatr (Paris); 1989 Jan; 36(1):20-5. PubMed ID: 2784652
[TBL] [Abstract][Full Text] [Related]
20. Haemophilus influenzae infections following licensure of the Hib vaccine.
Alexander WJ; Shaw JF; Holmes JR
N Engl J Med; 1987 Jul; 317(3):167-8. PubMed ID: 3496536
[No Abstract] [Full Text] [Related]
[Next] [New Search]
